ENANTA PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
30 September
ENANTA PHARMACEUTICALS INC has filed 823 SEC EDGAR filings since 21 Jun 2002

SEC filing history

Showing 1-25 of 822 matching filings.

Per page
25
Current page
1
SCHEDULE 13G/A File 005-87373

SCHEDULE 13G/A filing

Filing date
26 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
13 Mar 2026
Reporting date
11 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
13 Mar 2026
Reporting date
11 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
13 Mar 2026
Reporting date
11 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
13 Mar 2026
Reporting date
11 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
13 Mar 2026
Reporting date
11 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
13 Mar 2026
Reporting date
11 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-293390

EFFECT filing

Filing date
20 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-293390

UPLOAD filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
13 Feb 2026
Reporting date
12 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
13 Feb 2026
Reporting date
12 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
13 Feb 2026
Reporting date
12 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
13 Feb 2026
Reporting date
12 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
13 Feb 2026
Reporting date
12 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
13 Feb 2026
Reporting date
12 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-87373

SCHEDULE 13G/A filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .